Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romania has achieved a significant fiscal adjustment in the first five months of 2026, narrowing its budget deficit to RON 35.94 billion (€7.19 billion), or 1.75% of GDP.
Deloitte Technology Delivery Center announces the appointment of Emilia Dumitrescu as Managing Director, effective June 2026. She has also been promoted to Deloitte Partner and succeeds Marcus Williamson, Partner, Deloitte UK, upon the completion of his three-and-a-half-year mandate.
Enevo Group and Kraftfeld have signed a contract for the construction of a battery energy storage system (BESS) with a power of 110 MW and a capacity of 220 MWh, at Drăgăneşti-Olt, in Olt county, Romania.
Connections Consult announces the conclusion of two significant subsequent contracts with a public institution in Romania. Each of them has as its object migration services of cybersecurity applications and hardware and software accessories.
Copenhagen Infrastructure Partners (CIP), through its Growth Markets Fund II (GMF II), announced financial close for the 392 MW Peștera II onshore wind project in Constanța County. The project represents one of the larger investments in new renewable energy infrastructure in Romania and one of the larger project finance transactions in CEE.